Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria Participation in study EPO906A2120E1~* Age ≥ 18 years of age~* Life expectancy ≥ 3 months~* Histologically documented advanced solid tumors which have progressed after standard systemic therapy or for which standard systemic therapy does not exist~* Completed all PK sampling in the core study~Exclusion criteria~* Known diagnosis of human immunodeficiency virus (HIV) infection, hepatitis~* Female patients who are pregnant or breast feeding~* Patients with a severe and/or uncontrolled medical disease~Other protocol-defined inclusion/exclusion criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).